🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Erkan Demirkaya

Western University

ORCID: 0000-0003-4525-1789

Also affiliated with Sachs' Children and Youth Hospital

Biochemistry, Genetics and Molecular BiologyMedicineHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.576Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A decade of progress in juvenile idiopathic arthritis treatments and outcomes in Canada: results from ReACCh-Out and the CAPRI registry

Lara D. Veeken(2023)10.1093/rheumatology/kead560
Top 34%
0.576DataRank
Top 34%16 citations

Julie Barsalou, Daniah Basodan, Michelle Batthish, Susanne M Benseler, Roberta Berard +69 more

Papers

Driven by 8 papers — median percentile 66. Top paper: “The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist”.

The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist

Annals of the Rheumatic Diseases(2022)10.1136/annrheumdis-2021-221801
N/A
0.737DataRank · unranked
135 citations

Zehra Serap Arıcı, David Piskin, Sara Alehashemi, Daniel Aletaha, Karyl S. Barron +26 more

The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS)

Arthritis & Rheumatology(2023)10.1002/art.42636
N/A
0.590DataRank · unranked
50 citations

Ashley V. Geerlinks, Marta Wilejto, Kate F. Kernan, Melissa Hines, Micol Romano +26 more

A decade of progress in juvenile idiopathic arthritis treatments and outcomes in Canada: results from ReACCh-Out and the CAPRI registry

Lara D. Veeken(2023)10.1093/rheumatology/kead560
Top 34%
0.576DataRank
Top 34%16 citations

Julie Barsalou, Daniah Basodan, Michelle Batthish, Susanne M Benseler, Roberta Berard +69 more

The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin‐1 Mediated Autoinflammatory Diseases: Cryopyrin‐Associated Periodic Syndromes, Tumour Necrosis Factor Receptor‐Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin‐1 Receptor Antagonist

Arthritis & Rheumatology(2022)10.1002/art.42139
N/A
0.561DataRank · unranked
41 citations

Zehra Serap Arıcı, David Piskin, Sara Alehashemi, Daniel Aletaha, Karyl S. Barron +26 more

The role of epigenetic modifications in systemic autoinflammatory diseases

Current Opinion in Immunology(2025)10.1016/j.coi.2025.102599
N/A
0DataRank · unranked
1 citations

Desiré Casares‐Marfil, Erkan Demirkaya, Amr H. Sawalha, Kader Cetin Gedik

The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI, and AGS

Arthritis & Rheumatology(2022)10.1002/art.42087
N/A
0DataRank · unranked
47 citations

Lovro Lamot, Micol Romano, Erkan Demirkaya, David Piskin, Sofia Torreggiani +27 more

The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS)

Annals of the Rheumatic Diseases(2023)10.1136/ard-2023-224123
N/A
0DataRank · unranked
142 citations

Ashley V. Geerlinks, Marta Wilejto, Kate F. Kernan, Melissa Hines, Micol Romano +45 more

Next Generation Sequencing Based Multiplex Long-Range PCR for Routine Genotyping of Autoinflammatory Disorders

Frontiers in Immunology(2021)10.3389/fimmu.2021.666273
N/A
0DataRank · unranked
7 citations

Micol Romano, Erdi Keles, David Piskin, Seza Özen, Hakan Poyrazoğlu +3 more